Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Yes Bob, there's an Investormeet broadcast on Youtube.
In summary, there was a mass of information about the fields, the expected path to self funding, the equipement and materials details. All the stuff that a company that expects to be producing in a major way would spell out.
The one pause for thought that I read in to it was the part about US listing, which looks like a dead cert in the next year or so. If ISA's can't be transferred there, the uncertainty about whether a UK main listing would also be feasible left me a bit cloudy about if, when, and how to put more funds in.
Other than that, pantheon is now talking the talk of a much hugher market cap company in future
IMHO
Agreed Contango
Everyone can read the RNS information, and listen to the webinars, analyse the reports, and make their own judgement on risks. For me, David Hobbs being appointed has raised the profile amongst intelligent investors. The risk is one that he has been prepared to take on, reputationally and financially. I believe he has enough clout in funding matters to make investing here a sound proposition, but stress this is my decision, others should make their own
Credit where it's due, this is a much quicker performance improvement than expected.
Sensibly, we know that the pressure test data is being processed, which hopefully will lead to the conclusion of financing talks. Once that is tied up, a programme of future works can be set out. A greater level of certainty is clearly the key, perhaps today shows that it isn't too far away.
Hope so
The shares are placed with long term holders, so not likely to be traded in the way that the bond holder would if they had received shares in payment.
So the sp should be influenced by the desire of folks to get in at levels that David Hobbs and the board described as way too low.
Aren't you being a bit obvious.
I hope not, I hope you are not playing games with this share again. You know, find a share that has been illiquid for a while, then do a few buys and try to get speculation going?
Or am I just paranoid because it's happened a few times already.
The shots are direct competitors to Actimel, which can only claim immune benefits through their content of Vits B and D6. They actually make no health claim for the bacteria because it doesn't seem possible to scientifically prove there are any
Another alternative could be that the royalty is paid to DSM on future productions of Fruitflow, therefore beco9ming an invisible cost of goods in the accounts. No doubt DSM still demand their usual secrecy to throw potential buyers noff the scent of what their margins are.
It's a legitimate question, and one that I hope is possible for us to see an answer to. Not that I'm holding my breath over though.
Mol42
I think you are misreading some of the results
I agree that a 60k outflow is good news, but this will swing up and down in future reports according to stock levels and debtors v inflows.
The increase in debtors is solely down to the new business to business sales model. A further increase would be a welcome sign so long as sales volumes keep growing. This would be easier to finance without equity raises.
Extended terms are normal within industry, in my own trade 90 days is normal, 120/150 days are frequently offered to encourage larger stock holdings.
The main goal has to be adding more brands, especially more powerful ones, and they do demand favourable terms.
Just normal business IMHO
More or less agree with those comments.
Reasonably good sales, and sales pipeline, whilst we wasit for: a/ DSM to develop and commercialise a new area of health benefit (years away), and b/ ByHealth to get started with their undoubtedly strong marketing skills. (near term se hop)